OUTLOOK THERAPEUTICS INC (US: OTLK) — Healthcare · Share Price, Chart & Market Data
About: Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.32 (+9.83%)
OTLKOUTLOOK THERAPEUTICS INC
Loading watchlist status…
Trade OTLK now
OUTLOOK THERAPEUTICS INC share price
OTLK price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:24 pm GMT+0
OTLK price performance
-1.346%
5D
51.418%
1M
-52.258%
YTD
-78.709%
1Y
OTLK price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:24 pm GMT+0
OTLK details
OTLK Market Signals